Scale Your Commercial DTx Model to Accelerate Adoption Rates and Better Serve Global Patients
Digital therapeutics have the potential to change the healthcare delivery system, offering patients more fitting treatments to a host of illnesses. But to truly achieve mainstream success, the digital therapeutics industry must avoid becoming an echo chamber, and listen to all stakeholders to overcome challenges around effective distribution, evidence generation, partnership and commercial models.
To stem the tide of our most challenging diseases including cancer, depression, dementia, respiratory and immunological conditions, modern and innovative solutions are required beyond a pill. With CAGR at 23%, digital therapeutics will soon become a standard of care for patients enabling better treatment management. Beyond clinical validation, the industry must act now to strengthen stakeholder engagement, patient and clinicians’ voices and partnerships to achieve scalability.
The 5th Commercializing Clinically Validated Digital Therapeutics Summit, designed with DTx companies, pharma and clinicians, will return this December to address the industry’s major challenges such as improving user experience, clinical trial development, and standing out in a crowded market through open discussion and case-study led presentations.
Whether you’re a veteran at commercializing clinically validated digital therapeutics, looking for partnerships, or a new entrant to the field, you’ll leave this conference with practical lessons and essential connections needed to supercharge DTx commercial ambitions across 2022 and beyond.
World-Class Speaker Faculty Includes:
What Did Past Attendees Have To Say?
“Clinically Validated Digital Therapeutics was one of the most worthwhile conferences I've been to in a long time. There were excellent speakers, debates and it was a pleasure to attend”
Senior Global Digital Director, GSK
“Right of the bat, the inaugural conference on ‘Clinically Validated Digital Therapeutics’ brought together a high quality, deeply engaged audience that is at the core of the Digital Therapeutics movement”
Head of Digital Therapeutics, Novartis Institute for Biomedical Research
“Best networking ever!”
Chief Medical Officer, Tilak Healthcare
“The event brought together leaders from the digital therapeutics space and enabled everyone to have an open and honest discussion about the challenges we're facing, and importantly, how to come together and positively shape our industry!”
Founder & Managing Director, Volar Health